§13786-D. Prescribing and dispensing insulin
1. Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
A. "Insulin" includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation. [PL 2019, c. 666, Pt. B, §1 (NEW).]
B. "Insulin-related devices and supplies" means needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips. "Insulin-related devices and supplies" does not include insulin pump devices. [PL 2019, c. 666, Pt. B, §1 (NEW).]
[PL 2019, c. 666, Pt. B, §1 (NEW).]
2. Authorization. As authorized by the board in accordance with rules adopted under subsection 3, a pharmacist may dispense emergency refills of insulin and associated insulin-related devices and supplies by prescription drug order or standing order or pursuant to a collaborative practice agreement authorizing insulin to be dispensed. The insulin dispensed under this subsection must be in a quantity that is at least a 30-day supply unless the intended recipient requests a lesser quantity upon consultation with the pharmacist. The intended recipient shall provide evidence of a previous prescription from a practitioner and attest that a refill of that previous prescription may not be readily or easily obtained under the circumstances. Upon receiving evidence of a previous prescription from a practitioner, the pharmacist shall immediately notify that practitioner that an emergency refill of insulin was dispensed and instruct the recipient to seek follow-up care from the practitioner as soon as possible.
[PL 2021, c. 20, §1 (AMD).]
3. Rules; protocols. The board by rule shall establish standards for authorizing pharmacists to dispense insulin in accordance with subsection 2, including protocols for notifying practitioners when emergency refills of insulin are dispensed. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A.
[PL 2021, c. 20, §2 (AMD).]
SECTION HISTORY
PL 2019, c. 666, Pt. B, §1 (NEW). PL 2021, c. 20, §§1, 2 (AMD).
Structure Maine Revised Statutes
TITLE 32: PROFESSIONS AND OCCUPATIONS
Chapter 117: MAINE PHARMACY ACT
Subchapter 9: MISCELLANEOUS PROVISIONS
32 §13781. Generic and therapeutically equivalent substitution
32 §13783. Posting prices (REPEALED)
32 §13784. Patient information regulation
32 §13785. Patient profile record system regulation
32 §13786. Identification of persons prescribing medicines on hospital prescription blanks
32 §13786-A. Security requirements; rules
32 §13786-B. Partial dispensing of prescription for opioid medication
32 §13786-C. Dispensing of prescription of opioid medication; immunity
32 §13786-D. Prescribing and dispensing insulin
32 §13786-E. Prescribing, dispensing and administering HIV prevention drugs
32 §13786-F. Dispensing of emergency supplies of chronic maintenance drug
32 §13787. Hypodermic syringes; prescriptions (REPEALED)
32 §13787-A. Sale of hypodermic apparatus
32 §13788. Sale of poisonous drugs
32 §13789. Possession of drug samples
32 §13790. Using drugs not in prescription
32 §13792. Sale by certain methods prohibited
32 §13793. Adulterating and selling drugs
32 §13794. Labeling of prescriptions
32 §13795. Photographic proof of identification; discretion to sell or dispense; immunity
32 §13796. Retail sale of targeted methamphetamine precursors
32 §13797. Prescription drug price information
32 §13798. Expedited partner therapy
32 §13799. Consumer choice preserved
32 §13800. Access to distributed drugs
32 §13800-A. Liability for product of another; exemption
32 §13800-B. Prohibition on providing conversion therapy to minors